← SynDRA
LYSINE
SynDRA canonical compound SYN0000232 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | GPRC6A | KARS | SLC7A1 | SLC7A2 | SLC7A3 | SLC7A4 |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
All known targets
- GPRC6A
- GSR
- KARS1
- SLC7A1
- SLC7A2
- SLC7A3
- SLC7A4
- GSTP1
Mechanisms of action (all sources)
- serotonin receptor agonist
- GPRC6A AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APEX1
- HDAC6
- SLC16A10
- SLC22A4
- SLC7A5
Drug classes
- Analgesics
- Anti-Inflammatory Agents, Non-Steroidal
- Cyclooxygenase Inhibitors
- Platelet Aggregation Inhibitors
- mucolytic agent
ATC classes
- B05X · I.V. SOLUTION ADDITIVES
- ALL OTHER THERAPEUTIC PRODUCTS
Cross-references
Synonyms
- LEGUBETI
- L-Lysine
- L-(+)-Lysine
- lysine hydrochloride
- lysine HCl
- lysine acetate
- Lisina
- L-lysine
- Enisyl
- K3Z4F929H6
- (+)-S-Lysine
- tyrosine impurity b (ep impurity)
- lysine (ii)
- lysine acid
- h-Lys-oh
- (S)-Lysine
- Aminutrin
- alpha-Lysine
- L-lys
- Lysinum
- (S)-alpha,epsilon-Diaminocaproic acid
- LYS (IUPAC abbreviation)
- L-2,6-Diaminocaproic acid
- CHEBI:18019
- 2,6-diaminohexanoate
- 6-ammonio-L-norleucine
- DTXCID403232
- (2S)-6-amino-2-azaniumylhexanoate
- CHEBI:25094
- L-Lysine High
- RefChem:6459
- L-Lysine 7415
- L-Lysine High 7416
- B05XB03
- L-alpha,epsilon-Diaminocaproic Acid
- Hydrolysin
- Lysinum [Latin]
- Lisina [Spanish]
Reported adverse events
- Electrolyte imbalance
- Hypersensitivity
- Infection
- Pulmonary embolism
- Refeeding syndrome
- Alkalosis
- Extravasation
- Glycosuria
- Local reaction
- Metabolic acidosis
- Death
- Sepsis
Look up LYSINE in the interactive SynDRA portal →